• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Prevalence of SARS-CoV-2 among high-risk populations in Lom? (Togo) in 2020

tetano

Editor, Senior Moderator
PLoS One


. 2020 Nov 9;15(11):e0242124.
doi: 10.1371/journal.pone.0242124. eCollection 2020.
Prevalence of SARS-CoV-2 among high-risk populations in Lom? (Togo) in 2020


Wemboo Afiwa Halatoko[SUP] 1 [/SUP], Yao Rodion Konu[SUP] 2 3 [/SUP], Fifonsi Adjidossi Gbeasor-Komlanvi[SUP] 2 3 [/SUP], Arnold Junior Sadio[SUP] 2 3 [/SUP], Martin Kouame Tchankoni[SUP] 3 [/SUP], Koffi Segbeaya Komlanvi[SUP] 3 [/SUP], Mounerou Salou[SUP] 4 5 6 [/SUP], Ameyo Monique Dorkenoo[SUP] 5 7 [/SUP], Issaka Maman[SUP] 1 [/SUP], Am?t?p? Agbobli[SUP] 5 [/SUP], Majest? Ihou Wateba[SUP] 5 6 [/SUP], Komi S?raphin Adjoh[SUP] 5 6 [/SUP], Edem Goeh-Akue[SUP] 5 6 [/SUP], Yem-Bla Kao[SUP] 6 [/SUP], Innocent Kpeto[SUP] 6 [/SUP], Paul Pana[SUP] 6 [/SUP], Rebecca Kinde-Sossou[SUP] 7 [/SUP], Agbeko Tamekloe[SUP] 7 [/SUP], Jos?e Nayo-Ap?tsianyi[SUP] 7 [/SUP], Simon-Pierre Hamadi Assane[SUP] 7 [/SUP], Mireille Prine-David[SUP] 4 5 [/SUP], Sossinou Marcel Awoussi[SUP] 7 8 [/SUP], Mohaman Djibril[SUP] 5 8 [/SUP], Moustafa Mijiyawa[SUP] 5 7 [/SUP], Anoumou Claver Dagnra[SUP] 4 5 6 7 [/SUP], Didier Koumavi Ekouevi[SUP] 2 3 6 9 [/SUP]



Affiliations

Abstract

Background: In December 2019, the COVID-19 outbreak began in China and quickly spread throughout the world and was reclassified as a pandemic in March 2020. The first case of COVID-19 was declared in Togo on March 5. Two months later, few data were available to describe the circulation of the new coronavirus in the country.
Objective: This survey aimed to estimate the prevalence of SARS-CoV-2 in high-risk populations in Lom?.
Materials and methods: From April 23, 2020, to May 8, 2020, we recruited a sample of participants from five sectors: health care, air transport, police, road transport and informal. We collected oropharyngeal swabs for direct detection through real-time reverse transcription polymerase chain reaction (rRT-PCR) and blood for antibody detection by serological tests. The overall prevalence (current and past) of infection was defined by positivity for both tests.
Results: A total of 955 participants with a median age of 36 (IQR 32-43) were included, and 71.6% (n = 684) were men. Approximately 22.1% (n = 212) were from the air transport sector, 20.5% (n = 196) were from the police sector, and 38.7% (n = 370) were from the health sector. Seven participants (0.7%, 95% CI: 0.3-1.6%) had a positive rRT-PCR test result at the time of recruitment, and nine (0.9%, 95% CI: 0.4-1.8%) were seropositive for IgM or IgG against SARS-CoV-2. We found an overall prevalence of 1.6% (n = 15), 95% CI: 0.9-2.6%.
Conclusion: The prevalence of SARS-CoV-2 infection among high-risk populations in Lom? was relatively low and could be explained by the various measures taken by the Togolese government. Therefore, we recommend targeted screening.
 
Back
Top Bottom